20537 ⎘
Medicinal preparations containing organic active ingredients; Carbohydrates; Sugars; Derivatives thereof; Compounds having three or more nucleosides or nucleotides Double-stranded nucleic acids or oligonucleotides
MODIFIED DOUBLE-STRANDED POLYNUCLEOTIDE
#4202Treatment of cancer by inhibition of IGFBPs and clusterin
#4203siRNA targeting catenin, Beat-1 (CTNNB1)
#4204Methods and compositions for treating malaria
#4205Modified L-Nucleic Acid
#4206GABA release-regulating agent in cerebellum
#4207PAR-1 antagonists for use in the treatment or prevention of influenza virus type A infections
#4208Method of treating cancer with antibodies against long-form leukotriene B4 receptor BLT2
#4209Diagnostic and Therapeutic Uses for B Cell Maturation Antigen
#4210MODULATION OF GLUT4 GENE PROMOTER ACTIVITY BY AHNAK
#4211COMPOSITION FOR SUPPRESSING EXPRESSION OF TARGET GENE
#4212Small interfering RNAs and methods for prevention, inhibition and/or treatment of malignant progression of breast cancer
#4213CATIONIC POLYMER COATED MESOPOROUS SILICA NANOPARTICLES AND USES THEREOF
#4214Water-soluble drug carrier and process for producing the same
#4215Cationic lipids and methods for the delivery of therapeutic agents
#4216METHODS OF ALTERING BONE GROWTH BY ADMINISTRATION OF SOST OR WISE ANTAGONIST OR AGONIST
#4217DUAL VECTOR FOR INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS
#4218SERUM BIOMARKERS FOR MELANOMA METASTASIS
#4219Post-exposure therapy of influenza A infections
#4220Functionalized polysaccharides for active agent delivery
#4221CARRIER COMPONENT AND FABRICATION METHOD THEREOF
#4222Anti-IL-6 antibodies for the treatment of oral mucositis
#4223Methods and compositions for prevention or treatment of RSV infection
#4224Compositions and methods for silencing apolipoprotein C-III expression
#4225Lipid formulation
#4226HYDROGELS USED TO DELIVER MEDICAMENTS TO THE EYE FOR THE TREATMENT OF POSTERIOR SEGMENT DISEASES
#4227Lipid formulations for nucleic acid delivery
#4228RNAi-mediated inhibition of frizzled related protein-1 for treatment of glaucoma
#4229siRNA phospholipid conjugate
#4230Nucleic acid molecules that target the RHO1 small GTP-binding protein and confer resistance to coleopteran pests
#4231PROCESS FOR THE IDENTIFICATION OF COMPOUNDS FOR TREATING CANCER
#4232Method for the preparation of micro-RNA and its therapeutic application
#4233Trialkyl cationic lipids and methods of use thereof
#4234Short hairpin RNA for gene knockdown of NR1 subunit of the N-methyl-D-aspartate receptor and its application on pharmaceutics
#4235Methods of inducing tissue regeneration
#4236TREATMENT OF COLLAGEN GENE RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO A COLLAGEN GENE
#4237Use of inhibitors of Zdhhc2 activity for modulation of adipogenesis
#4238Use of inhibitors of leukotriene B4 receptor BLT2 for treating asthma
#4239METHOD AND COMPOSITION FOR TREATING CANCER
#4240Targeting EN2, PAX2, and/or DEFB1 for treatment of prostate conditions
#4241USP47 inhibitors and methods to induce apoptosis
#4242MICRONEEDLE ARRAYS FOR ACTIVE AGENT DELIVERY
#4243NUCLEIC ACID MOLECULES AND USES THEREOF
#4244Disabling autophagy as a treatment for lysosomal storage diseases
#4245Treatment of insulin gene (INS) related diseases by inhibition of natural antisense transcript to an insulin gene (INS)
#4246Methods for modulating the expression and aggregation of CAG-expanded gene product in cells and methods for identifying agents useful for doing the same
#4247COMPOSITIONS AND METHODS TO INDUCE TARGETED APOPTOSIS
#4248Methods for treating nicotinic acetylcholine receptor associated diseases
#4249Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene
#4250MODULATION OF TIMP1 AND TIMP2 EXPRESSION
#4251USE OF PKC ISOZYMES FOR DIAGNOSIS AND TREATMENT OF NEUROBLASTOMA
#4252Molecular targets for ALS and related disorders
#4253Use of DR6 and p75 antagonists to promote survival of cells of the nervous system
#4254SiRNA targeting catenin, beta-1 (CTNNB1)
#4255Carbohydrate conjugates as delivery agents for oligonucleotides
#4256Single nucleotide polymorphism (SNP) targeting therapies for the treatment of huntington'S disease
#4257siRNA targeting spleen tyrosine kinase
#4258Amphoteric liposomes, a method of formulating an amphoteric liposome and a method of loading an amphoteric liposome
#4259DETECTION AND TREATMENT OF AUTOIMMUNE DISORDERS
#4260Organic compositions to treat HSF1-related diseases
#4261Organic compositions to treat HSF1-related diseases
#4262dsRNA for treating viral infection
#4263Transcriptome transfer produces cellular phenotype conversion
#4264Multicomponent degradable cationic polymers
#4265Methods for determining agents that treat or prevent obesity and/or obesity related diseases and methods for treatment therewith
#4266MODULATION OF PILR RECEPTORS TO TREAT MICROBIAL INFECTIONS
#4267Anti-IL-6 antibodies for the treatment of anemia
#4268Organic compositions to treat Beta-ENaC-related diseases
#4269REGULATION OF AGING BY MODULATION OF MITOCHONDRIAL FUNCTION
#4270Use of LNA ApoB antisense oligomers for the treatment of acute coronary syndromes
#4271METHODS AND COMPOSITIONS FOR REDUCING TARGET GENE EXPRESSION USING COCKTAILS OF siRNAS OR CONSTRUCTS EXPRESSING siRNAS
#4272THERAPEUTIC AGENT AND ASSAY
#4273FRAGMENT OF SECRETED HEAT SHOCK PROTEIN-90ALPHA (Hsp90ALPHA) AS VACCINES OR EPITOPE FOR MONOCLONAL ANTIBODY DRUGS OR TARGET FOR SMALL MOLECULE DRUGS AGAINST A RANGE OF SOLID HUMAN TUMORS
#4274Nucleic acid ligands to LL37
#4275Potent anti APOB antisense compounds
#4276ANTI-CANCER AGENT, METHOD FOR INDUCING APOPTOSIS OF CANCER CELLS, AND METHOD FOR SCREENING FOR ANTI-CANCER AGENT
#4277Organic compositions to treat beta-ENaC-related diseases
#4278Organic compositions to treat Beta-ENaC-related diseases
#4279PEPTIDE/PARTICLE DELIVERY SYSTEMS
#4280METHODS AND COMPOSITIONS RELATED TO SYNERGISTIC RESPONSES TO ONCOGENIC MUTATIONS
#4281Immobilization Particles for Removal of Microorganisms and/or Chemicals
#4282Mitochondrial function-improving agent
#4283Compositions for conferring tolerance to viral disease in social insects, and the use thereof
#4284Mitochondrial enhancement of cells
#4285EXPRESSION VECTORS WHICH INHIBIT SYNTHESIS OF CATALASE AND USES THEREOF
#4286DOUBLE-STRANDED OLIGONUCLEOTIDES
#4287Mitochondrial enhancement of cells
#4288Treatment of paraoxonase 1 (PON1) related diseases by inhibition of natural antisense transcript to PON1
#4289Treatment of transcription factor E3 (TFE3) and insulin receptor substrate 2(IRS2) related diseases by inhibition of natural antisense transcript to TFE3
#4290NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS
#4291Sensitizing agents for cancer therapy, methods of use and methods for the identification thereof
#4292Pharmaceutical compositions and related methods of delivery
#4293Methods for modulating resistance to apoptosis using KLK6
#4294Medical Devices, Wound Dressings, and Methods for Dressing Wounds
#4295Head-and-neck tumor proliferation inhibitor
#4296Modified oligonucleotide and its preparation and application
#4297Methods For Diagnosing And Treating A Renal Disease In An Individual
#4298Cancer Treatment Targeting BRCA1-IRIS
#4299Methods And Compositions Related To Synergistic Responses To Oncogenic Mutations
#4300Bispecific antisense oligonucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using same
#4301Methods for affecting homology-directed DNA double stranded break repair
#4302Particulate pharmaceutical composition
#4303C-CBL AND ANTAGONISTS THEREOF FOR THE TREATMENT AND DIAGNOSIS OF CANCER
#4304METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING PRURITIS
#4305Application of highly conserved domain sequences from viral genome as template to design therapeutic slirnas
#4306Anti-trypanosomal peptides and uses thereof
#4307LEUKEMIA STEM CELL MARKERS
#4308Polymeric nano-carriers with a linear dual response mechanism and uses thereof
#4309BIODEGRADABLE POLY(BETA-AMINO ESTERS) AND USES THEREOF
#4310Methods and compositions involving miRNA and miRNA inhibitor molecules
#4311Lipids, lipid complexes and use thereof
#4312Methods and compositions for the treatment of cancer or other diseases
#4313Fine particles of crystalline polyol, and method of preparing same
#4314Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factor
#4315Treatment of neurological disorders by dsRNA administration
#4316miR-33 INHIBITORS AND USES THEREOF
#4317Oligonucleotide analogs as therapeutic agents
#4318Diagnosis and treatment of drug-resistant Ewing'S sarcoma
#4319METHODS AND COMPOSITIONS FOR SELECTING SIRNA OF IMPROVED FUNCTIONALITY
#4320Apparatus and methods for making nanosomes loaded with nucleic acid
#4321Oligonucleotide chelate complexes
#4322Treatment of dystrophin family related diseases by inhibition of natural antisense transcript to DMD family
#4323Treatment of ABCA1 gene related diseases by inhibition of a natural antisense transcript to ABCA1
#4324TREATMENT OF TRISTETRAPROLINE (TTP) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO TTP
#4325JARID1B FOR TARGET GENE OF CANCER THERAPY AND DIAGNOSIS
#4326COMBINATION OF A TLR3 LIGAND AND A CHEMOTHERAPY AGENT WHICH ACTS ON THE INTRINSIC "APOPTOSIS" PATHWAY IN THE TREATMENT OF CANCER
#4327Delivery of dsRNA to arthropods
#4328Liposome compositions and methods of use thereof
#4329Brain Tumor Stem Cell Differentiation Promoter, and Therapeutic Agent for Brain Tumor
#4330RNA Interference Mediated Inhibition of Signal Transducer and Activator of Transcription 6 (STAT6) Gene Expression Using Short Interfering Nucleic Acid (siNA)
#4331METHODS FOR IDENTIFYING AND COMPOUNDS USEFUL FOR THE DIAGNOSIS AND TREATMENT OF DISEASES INVOLVING INFLAMMATION
#4332PHARMACEUTICAL COMPOSITION FOR TREATING OBESITY OR DIABETES
#4333Conserved HBV and HCV sequences useful for gene silencing
#4334Antisense antiviral compounds and methods for treating a filovirus infection
#4335Chemical modifications of monomers and oligonucleotides with cycloaddition
#4336Tyrosine kinase receptor TYRO3 as a therapeutic target in the treatment of cancer
#4337RNA Interference Mediated Inhibition of GATA Binding Protein 3 (GATA3) Gene Expression Using Short Intefering Nucleic Acid (siNA)
#4338siRNA targeting VEGFA and methods for treatment in vivo
#4339Biodegradable lipids for the delivery of active agents
#4340Lipids and compositions for the delivery of therapeutics
#4341RNA Interference Mediated Inhibition of Signal Transducer and Activator of Transcription 1 (STAT1) Gene Expression Using Short Interfering Nucleic Acid (siNA)
#4342PHD2 inhibition for blood vessel normalization, and uses thereof
#4343Compositions and methods for inhibiting expression of mutant EGFR gene
#4344Sustained release siRNA for ocular drug delivery
#4345Cancer antigen eEF2
#4346Nanoparticles containing plymeric nucleic acid homologs, pharmaceutical composition and articles of manufacture containing same and methods of use thereof
#4347PHARMACEUTICAL COMPOSITION CONTAINING A DRUG AND SIRNA
#4348Methods of treating thyroid eye disease
#4349ALPHA SYNUCLEIN TOXICITY
#4350METHODS AND COMPOSITIONS TO REDUCE LIVER DAMAGE ASSOCIATED WITH CONDITIONS OR THERAPIES THAT AFFECT THE IMMUNE SYSTEM
#4351Nanoparticle compositions and methods for improved oral delivery of active agents
#4352Pharmaceutical compositions and related methods of delivery
#4353Double-stranded ribonucleic acids with rugged physico-chemical structure and highly specific biologic activity
#4354Target host factors for treating viral infection
#4355T CELL RECEPTOR AND NUCLEIC ACID ENCODING THE RECEPTOR
#4356Viral Therapy and Prophylaxis Using Nanotechnology Delivery Techniques
#4357TREATING CHRONIC FATIGUE SYNDROME AND PROLONGED QT INTERVAL
#4358RNA Interference Mediated Inhibition of the Nerve Growth Factor Beta Chain (NGFB) Gene Expression Using Short Interfering Nucleic Acid (siNA)
#4359Methods used in identifying glioblastoma
#4360siRNA targeting cyclin-dependent kinase 4 (CDK4)
#4361METHODS OF PROGNOSTICATING AND TREATING EWING SARCOMA/PNET AND OTHER NEOPLASMS
#4362Targets for treatment of hypercholesterolemia
#4363DOWN-REGULATION OF COLD SHOCK PROTEINS FOR CANCER TREATMENT
#4364METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES
#4365RNAi modulation of RSV and therapeutic uses thereof
#4366Compositions and methods for diminishing viral infection and inflammation associated with viral infection
#4367Lipids and compositions for the delivery of therapeutics
#4368Lipids and compositions for the delivery of therapeutics
#4369Platelet derived growth factor receptor supports cytomegalovirus infectivity
#4370Novel therapy for anxiety
#4371METHODS FOR IDENTIFYING AND COMPOUNDS USEFUL FOR THE DIAGNOSIS AND TREATMENT OF DISEASES INVOLVING INFLAMMATION
#4372Reducing IRF4, DUSP22, or FLJ43663 polypeptide expression
#4373Method and pharmaceutical composition for treating psoriasis, squamous cell carcinoma and/or parakeratosis by inhibiting expression of squamous cell carcinoma-related antigen
#4374Methods and uses for inhibiting platelet coagulation
#4375Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
#4376Treatment of chronic inflammatory respiratory disorders
#4377METHODS AND COMPOSITIONS FOR ASSESSING AND TREATING METASTASIS, METASTATIC CANCER, AND POTENTIAL FOR METASTASIS
#4378LIPIDS, LIPID COMPLEXES AND USE THEREOF
#4379Reagents and methods for treating cancer
#4380ANTAGONISTS OF MIR-155 FOR THE TREATMENT OF INFLAMMATORY LIVER DISEASE
#4381Method for prongf assay for in vitro diagnosis of cancer in particular breast, thyroid or lung cancer and therapeutic use of prongf
#4382Antisense modulation of interleukins 17 and 23 signaling
#4383RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions
#4384Regeneration of Pancreatic Islets and Reversal of Diabetes by Islet Transcription Factor Genes Delivered in Vivo
#4385INHIBITION OF EMMPRIN TO TREAT MULTIPLE SCLEROSIS
#4386Methods of diagnosing and treating fibrosis
#4387Recombinant vectors and hosts comprising human glucokinase encoding gene
#4388Multiblock copolymers
#4389Pdia4, target of cytopiloyne derivatives, for tumor diagnosis and treatment
#4390Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells
#4391Methods and compositions to generate and control the effector profile of T cells by simultaneous loading and activation of selected subsets of antigen presenting cells
#4392Detection and treatment of non-dermal fibrosis
#4393siRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B)
#4394Cancer cell death inducing agent having effects of potentiating anticancer drug against anticancer-drug-resistant cancer
#4395Spinal muscular atrophy treatment via targeting SMN2 catalytic core
#4396Porous nanoparticle supported lipid bilayer nanostructures
#4397Lipid formulated compositions and methods for inhibiting expression of Serum Amyloid A gene
#4398Organic compositions to treat beta-ENaC-related diseases
#4399STING (STIMULATOR OF INTERFERON GENES), A REGULATOR OF INNATE IMMUNE RESPONSES
#4400METHODS AND KITS USED IN IDENTIFYING GLIOBLASTOMA
#4401THERAPEUTIC AGENT FOR MLL LEUKEMIA AND MOZ LEUKEMIA OF WHICH MOLECULAR TARGET IS M-CSF RECEPTOR, AND USE THEREOF
#4402RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS
#4403METHODS OF IDENTIFYING REGULATORS OF CELLULAR PROTEOSTASIS
#4404PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY
#4405Anti periodontitis-causing microorganism agent and medical or dental materials using the same
#4406Amino lipids and methods for the delivery of nucleic acids
#4407Transferrin/transferrin receptor-mediated siRNA delivery
#4408Methods Of Treating And Preventing Glucose Toxicity
#4409Modulation of axon degeneration
#4410MEX3C REGULATION AND TARGET TO CONTROL OBESITY AND DIABETES
#4411CHONDROCYTE-LIKE CELL, AND METHOD FOR PRODUCING SAME
#4412Compositions and methods for inhibition of nucleic acids function
#4413Compositions and methods for inhibiting expression of CD274/PD-L1 gene
#4414Tumor specific delivery of therapeutic agents via liposomase
#4415Composition comprising expression or activity inhibitors of ninjurin1 for the prevention and treatment of inflammatory disease
#4416Method for inhibiting function of micro-RNA
#4417Post-transcriptional regulation of RNA-related processes using encoded protein-binding RNA aptamers
#4418RIG-Like Helicase Innate Immunity Inhibits VEGF-Induced Tissue Responses
#4419Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancer
#4420MATERIALS AND METHODS FOR PREVENTING OR TREATING NEURODEGENERATIVE CONDITIONS ASSOCIATED WITH ABETA PEPTIDE ACCUMULATION
#4421Compounds and pharmaceutical compositions for the treatment of viral infections
#4422Inhibitory RNA for modulating the molecular function of ZFAT gene
#4423Identification of a novel repressor on IFN-lambda promoter and siRNA against ZEB1 and BLIMP-1 to increase IFN-lambda gene activity
#4424METHODS FOR THE REGULATION OF THE PROSTAGLANDIN F SYNTHASE (PGFS) ACTIVITY OF AKR1B1 AND USES THEREOF
#4425TIKI1 AND TIKI2, WNT INHIBITORS
#4426Compositions and methods for inhibiting expression of the PCSK9 gene
#4427Low density lipoprotein receptor-mediated siRNA delivery
#4428Nanoparticle-based gene delivery systems
#4429Lipid vesicle compositions and methods of use
#4430PEGYLATED POLYPLEXES FOR POLYNUCLEOTIDE DELIVERY
#4431Two alkylresorcinol synthase genes from sorghum; cloning, expression, transformation and characterization
#4432iRNA agents targeting VEGF
#4433Methods and compositions for treating a subject for central nervous system (CNS) injury
#4434Methods of inducing photosensitivity by targeting channelrhodopsin-2 and halorhodopsin to subcellular regions of retinal ganglion cells
#4435METHODS AND COMPOSITIONS FOR TREATMENT OF MUSCULAR DYSTROPHY
#4436Gene defects and mutant ALK kinase in human solid tumors
#4437Block copolymers and uses thereof
#4438SDF-1 binding nucleic acids and the use thereof
#4439Treatment of scleroderma
#4440Method for diagnosing and/or treating tumor
#4441TREATMENT AND/OR PREVENTION OF PEANUT INDUCED ANAPHYLAXIS
#4442Use of human Biliverdin reductase and fragments thereof protein kinase C-δ and ERK related conditions
#4443Pharmaceutical containing HIF-1 alpha and HIF-2 alpha expression inhibitor
#4444Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
#4445Compositions for targeted delivery of siRNA
#4446Method for treating breast cancer using adenine nucleotide translocator 2 (ANT2) siRNA or ANT2 shRNA
#4447Molecular Determinants Associated With Prostate Cancer And Methods Of Use Thereof
#4448POLYPEPTIDES AND POLYNUCLEOTIDES FOR ARTEMIN AND RELATED LIGANDS, AND METHODS OF USE THEREOF
#4449Therapeutic compositions
#4450ON01910.Na enhances chemotherapeutic agent activity in drug-resistant tumors
#4451Compositions and methods for silencing Ebola virus gene expression
#4452Injectable polydeoxyribonucleotide composition for the treatment of osteoarticular diseases
#4453Treatment of cancer by inhibition of IGFBPs and clusterin
#4454Compositions and methods for silencing apolipoprotein B
#4455Treatment of cancer by inhibition of IGFBPs and clusterin
#4456RNAi-mediated inhibition of frizzled related protein-1 for treatment of glaucoma
#4457METHODS FOR P2RY5 MEDIATED REGULATION OF HAIR GROWTH AND MUTANTS THEREOF
#4458PTHrP, its isoforms and antagonist thereto in the diagnosis and treatment of disease
#4459Composition for suppressing expression of target gene
#4460Method for treating fibromyalgia
#4461Modulation of BCL11A for treatment of hemoglobinopathies
#4462Modulation of HSP47 expression
#4463Method of suppressing pRb deficiency-induced tumor formation
#4464Methods of treating chemoresistance and relapse in cancer cells
#4465VACCINATION REGIMEN
#4466RNAi compound targeted to thrombospondin-1 and applications thereof
#4467Organic compositions to treat HSF1-related diseases
#4468Targeting ABCB5 for cancer therapy
#44695′ triphosphate oligonucleotide with blunt end and uses thereof
#4470Compositions, devices and methods for treatment of Huntington's disease through intracranial delivery of sirna
#4471Potentiator of activity of anti-cancer agent and use thereof, and biomarker for prediction of prognosis in cancer patient and use thereof
#4472Lactic acid bacteria-derived double-stranded RNA
#4473STABILIZATION AND DELIVERY OF NUCLEIC ACID COMPLEXES
#4474Double-stranded polynucleotide
#4475Inhibition of filovirus entry into cells and uses thereof
#4476METHODS AND COMPOSITIONS FOR REDUCING TARGET GENE EXPRESSION USING COCKTAILS OF siRNAS OR CONSTRUCTS EXPRESSING siRNAS
#4477Amphiphilic block copolymers for nucleic acid delivery
#4478Methods of modulating angiogenesis via TRPV4
#4479Compositions and methods for delivering inhibitory oligonucleotides
#4480Oligonucleotides for treating inflammation and neoplastic cell proliferation
#4481Diblock copolymers and polynucleotide complexes thereof for delivery into cells
#4482Compositions and methods for treatment of ear disorders
#4483Composition and method for treating atherosclerosis, method for determining if a subject has atherosclerosis and method of screening an anti-atherosclerotic drug
#4484PEGYLATED POLYPLEXES FOR POLYNUCLEOTIDE DELIVERY
#4485Compounds, composition, methods, targets for cancer therapy
#4486RNAi-mediated inhibition of tumor necrosis factor α-related conditions
#4487Compositions and Methods for Producing Vascular Occlusion using a Solid-phase Platelet Binding Agent
#4488METHODS OF TREATING KIDNEY DISEASE
#4489IMPROVED GENE SILENCING METHODS
#4490NUCLEIC ACID CAPABLE OF CONTROLLING DEGRANULATION OF MAST CELL
#4491Methods for bone treatment by modulating an arachidonic acid metabolic or signaling pathway
#4492Micellic assemblies
#4493Formulations comprising aminosterols
#4494Adenoviral-based vectors
#4495Interfering RNA molecules
#4496Therapeutic uses of inhibitors of RTP801
#4497siRNA targeting spleen tyrosine kinase
#4498Bacterially derived intact minicells that encompass plasmid free functional nucleic acid for in vivo delivery to mammalian cells
#4499Modulating levels of RNA-binding proteins for the treatment of breast cancer
#4500Methods of Detecting Cells with a Disrupted Cell Membrane, Cells Infected with A Pathogen, Dying Cells or Dead Cells